S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:CRT

Cross Timbers Royalty Trust (CRT) Stock Price, News & Analysis

$14.41
+1.27 (+9.67%)
(As of 04:37 PM ET)
Today's Range
$13.14
$14.60
50-Day Range
$12.67
$17.62
52-Week Range
$12.50
$26.10
Volume
94,271 shs
Average Volume
37,079 shs
Market Capitalization
$86.46 million
P/E Ratio
7.47
Dividend Yield
1.60%
Price Target
N/A

Cross Timbers Royalty Trust MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.04% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.77mentions of Cross Timbers Royalty Trust in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.84 out of 5 stars

Oils/Energy Sector

175th out of 227 stocks

Oil Royalty Traders Industry

2nd out of 5 stocks

CRT stock logo

About Cross Timbers Royalty Trust Stock (NYSE:CRT)

Cross Timbers Royalty Trust operates as an express trust in the United States. It holds 90% net profits interests in certain producing and nonproducing royalty and overriding royalty interest properties in Texas, Oklahoma, and New Mexico; and 75% net profits working interest in four properties in Texas and three properties in Oklahoma. Cross Timbers Royalty Trust was founded in 1991 and is based in Dallas, Texas.

CRT Stock Price History

CRT Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Cross Timbers Royalty Trust (CRT)
See More Headlines
Receive CRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cross Timbers Royalty Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/14 Dividend
2/28/2024
Dividend Payable
3/14/2024
Ex-Dividend for 4/12 Dividend
3/27/2024
Dividend Payable
4/12/2024
Today
4/19/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Oil royalty traders
Sub-Industry
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$13.13 million
Pretax Margin
51.61%

Debt

Sales & Book Value

Annual Sales
$12.30 million
Cash Flow
$2.09 per share
Book Value
$0.45 per share

Miscellaneous

Free Float
5,436,000
Market Cap
$85.68 million
Optionable
Not Optionable
Beta
0.59
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

CRT Stock Analysis - Frequently Asked Questions

How have CRT shares performed in 2024?

Cross Timbers Royalty Trust's stock was trading at $17.56 at the beginning of 2024. Since then, CRT stock has decreased by 17.9% and is now trading at $14.41.
View the best growth stocks for 2024 here
.

Are investors shorting Cross Timbers Royalty Trust?

Cross Timbers Royalty Trust saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 2,100 shares, a decrease of 58.0% from the March 15th total of 5,000 shares. Based on an average daily trading volume, of 37,400 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company's stock are short sold.
View Cross Timbers Royalty Trust's Short Interest
.

When is Cross Timbers Royalty Trust's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our CRT earnings forecast
.

How often does Cross Timbers Royalty Trust pay dividends? What is the dividend yield for Cross Timbers Royalty Trust?

Cross Timbers Royalty Trust declared a monthly dividend on Monday, March 18th. Investors of record on Thursday, March 28th will be paid a dividend of $0.019 per share on Friday, April 12th. This represents a $0.23 annualized dividend and a yield of 1.58%. The ex-dividend date is Wednesday, March 27th.
Read our dividend analysis for CRT
.

Is Cross Timbers Royalty Trust a good dividend stock?

Cross Timbers Royalty Trust (NYSE:CRT) pays an annual dividend of $0.23 per share and currently has a dividend yield of 1.80%. The dividend payout ratio is 11.92%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CRT.

What other stocks do shareholders of Cross Timbers Royalty Trust own?
How do I buy shares of Cross Timbers Royalty Trust?

Shares of CRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CRT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners